Platinum Industries IPO Basis of Allotment

Our Company was incorporated under the provisions of the Limited Liability Partnership Act, 2008 in the name and style of ‘Platinum Industries LLP" on August 19,2016. Platinum Industries LLP was thereafter converted into a private limited company ‘Platinum Industries Private Limited" pursuant to the provisions of Chapter XXI of the Companies Act, 2013 vide Certificate of Incorporation dated July 09,2020 issued by the Central Registration Centre, Registrar of Companies. Subsequently, our Company has been converted into a public limited company and the name of our Company changed to "Platinum Industries Limited" pursuant to a special resolution passed at the Extra-Ordinary General Meeting of our Company held on March 31,2023 and a fresh Certificate of Incorporation dated June 02,2023 has been issued by the RoC. For details in relation to the change in our Registered Office of our Company, see '‘History and Certain Corporate Matters" beginning on page 217 of the Prospectus dated March 01,2024 filed with the RoC (‘Prospectus").

THE COMMENCEMENT OF TRADING OF THE EQUITY SHARES OF OUR COMPANY ON THE STOCK EXCHANGES SHALL BE WITH EFFECT FROM TUESDAY, MARCH 05, 2024. OUR COMPANY WILL BE LISTED ON T+3 DAY (T BEING THE ISSUE CLOSING DATE) IN TERMS OF THE TIMELINES PRESCRIBED UNDER THE SEBI CIRCULAR NO. SEBI/HO/CFD/TPD1/CIR/P/2023/140 DATED AUGUST 09,2023.

Our Company has filed the Prospectus dated March 01,2024 with the RoC, and the Equity Shares are proposed to be listed on the National Stock Exchange of India Limited ("NSE'') and BSE Limited ("BSE") and trading is expected to commence on March 05,2024.

INITIAL PUBLIC OFFER OF 13,761,225 EQUITY SHARES OF FACE VALUE OF Rs. 10/- EACH ("EQUITY SHARES") OF PLATINUM INDUSTRIES LIMITED ("COMPANY OR ISSUER") FOR CASH AT A PRICE OF Rs. 171 PER EQUITY SHARE (INCLUDING A SHARE PREMIUM OFRs. 161 PER EQUITY SHARE) ("ISSUE PRICE") AGGREGATING TO Rs. 2,353.17 MILLION ("ISSUE"). THE ISSUE SHALL CONSTITUTE 25.05% OF THE POST-ISSUE PAID-UP EQUITY SHARE CAPITAL OF OUR COMPANY.

1. Geographic Risk: We operate out of a single Manufacturing Facility which is located at Palghar, Maharashtra. Any localized social unrest, natural disaster or breakdown of services or any other natural disaster in and around Palghar, Maharashtra or any disruption in production at, or shutdown of, our manufacturing unit could have material adverse effect on our business and financial condition.

2. Past defaults in repayment of dues: In the past, our promoter group members M/s. D.B. Rana & Co. and Platinum Chemicals Limited have defaulted in repayment of loan to their respective lenders. The said matters have been subsequently settled by payment of an aggregate sum of Rs.8.50 million under One Time Settlement ("OTS") Scheme issued by the lender.

3. Dependence on Technical Collaboration Agreement: We have a long-term Technical Collaboration Agreement with HMS Concept E.U., a sole proprietorship concern of Dr. Michael Schiller under the laws of Austria for providing know-how in relation to our business and manufacture of products. Under Technical Collaboration Agreement, we have paid a sum of Rs.12.78 million, Rs.22.02 million, Rs.13.33 million and Rs.8.39 million for the period ended September 30,2023, Fiscal 2023, Fiscal 2022 and Fiscal 2021, respectively. If this Technical Collaboration Agreement is terminated or not renewed on terms acceptable to us, it could have a material adverse effect have an adverse impact on our business, results of operations and financial condition.

4. Expansion Risk: We are in the process of expanding our operations and establishing a network of distributors & customers in regions where we do not have a significant presence or prior experience. Any failure to expand into these new regions could adversely affect our sales, financial condition, result of operations and cash flows.

5. Dependency on Customers: We are dependent on a few customers for a major part of our revenues. In the period ended September 30, 2023 and in Fiscal 2023, Fiscal 2022 and Fiscal 2021, our revenue from our top 10 customers was Rs.994.09 million, Rs.2,024.34 million, Rs.1,536.05 million and Rs.781.88 million, respectively, representing 91.10%, 86.49%, 83.41 % and 87.71 %, respectively of total sales.

6. Risk of time and cost overrun: If there are delays in setting up the Proposed Facilities or if the costs of setting up and the possible time or cost overruns related to the Proposed Facilities or the purchase of plant and machinery for the Proposed Facilities are higher than expected, it could have a material adverse effect on our financial condition, results of operations and growth prospects.

7. Under-utilization of our manufacturing capacities: Our manufacturing capacities are currently under-utilized and an inability to effectively utilize our expanded manufacturing capacities could have an adverse effect on our business, future prospects and future financial performance. Our overall capacity utilization for Lead based stabilizers, Nonlead based stabilizers, CPVC Additives and Lubricants are as follows:

8. Supplier Concentration Risk: We do not have long-term agreements with our suppliers for raw materials. In the period ended September 30,2023 and in Fiscal 2023, Fiscal 2022 and Fiscal 2021, our purchase of raw materials from our top 10 suppliers was Rs.444.75 million, Rs.681.12 million, ^687.42 million and ^350.50 million, respectively, representing 37.15%, 29.10%, 37.33% and 39.32%, respectively of revenue from operations.

9. Dependence on Pipes and tubes industry: Our Company is dependent on the demand from the industries where our products find application such as PVC pipes and tubes,

PVC profiles, PVC fittings and electrical wires and cables. For the period ended September 30, 2023 and in Fiscal 2023, Fiscal 2022 and Fiscal 2021, our revenue from pipes and tubes industry was Rs.1,113.85 million, Rs.2,165.70 million, Rs.1,532.00 million and Rs.748.51 million, respectively, representing 93.05%, 92.52%, 83.19% and 89.14%, respectively of revenue from operations.

10. Past Non-Compliances: Our Company and Director (Parul Rana) have filed 5 compounding/adjudication applications before the relevant authorities under the Companies Act for certain past non-compliances which may attract penalties.

11. The BRLM associated with the Issue has handled 6 Main board public issues and 9 SME public issues in the past three years, out of which 1 issue closed below the issue price on listing date.

12. Average cost of acquisition per Equity Share by our Promoters Krishna Dushyant Rana and Parul Krishna Rana isRs.0.26 (As certified by M/s. AMS & Co., Chartered Accountants, by way of their certificate dated January 23,2024.) and the Issue Price at upper end of the Price Band is Rs. 171 /- per Equity Share.

13. Weighted Average Return on Net Worth of our Company for Fiscals 2023,2022 and 2021 is 75.06%.

14. The weighted average cost of acquisition of all Equity Shares acquired in last three years, 18 months and one year preceding the date of the Prospectus by are as follows:

'As certified by M/s. AMS & Co., Chartered Accountants by way of their certificate dated January 23,2024.

Note: Given that the weighted average cost of acquisition for all Equity shares acquired in the three years and 18 months before the Prospectus is f 0.0014 per Equity Share, this amount is considered negligible. Therefore, the upper limit of the price band is not applicable.

15. Weighted average cost of acquisition, floor price and cap price:

Investors should read the Prospectus carefully, including the "Risk Factors" on page 38 of the Prospectus before making any investment decision.

The Issue was made in terms of Rule 19(2)(b) of the Securities Contracts (Regulation) Rules. 1957, as amended f SCRR') read with Regulation 31 of the SEBIICDR Regulations. The Issue was made through the Book Building Process in accordance with Regulation 6(1) of the SEBI ICDR Regulations, wherein not more than 50% of the Issue was available for allocation on a proportionate basis to Qualified Institutional Buyers CQIB Portion'), provided that our Company, in consultation with the Book Running Lead Manager, allocated up to 60% of the QIB Portion to Anchor Investors and the basis of such allocation will be on a discretionary basis by our Company, in consultation with the BRIM, in accordance with the SEBI ICDR Regulations (the 'Anchor Investor Portion"), of which one-third was reserved for domestic Mutual Funds, subject to valid Bids being received from the domestic Mutual Funds at or above the price at which allocation ts made to Anchor Investors ('Anchor Investor Allocation Price'). In the event of under-subscription or non-allocation in the Anchor Investor Portion, the balance Equity Shares were added to the QIB Portion (other than the Anchor Investor Portion) (the 'Net QIB Portion'). Further. 5% of the Net QIB Portion was available for allocation on a proportionate basis to Mutual Funds only and the remainder of the Net QIB Portion was available for allocation on a proportionate basis to all QIB Bidders including Mutual Funds, subject to valid Bids being received at or above the Issue Price. Further, not less than 15% of the Issue was available for allocation to Nils Non-lnstitutional Category") of which one-third of the Non-lnstitutional Category was available for allocation to Bidders with an application size of more than T0.20 million and up to Rs. 1.00 million and two-thirds of the Non-lnstitutional Category was available for allocation to Bidders with an application size of more than Rs.1.00 million and under-subscription in either of these two sub- categones of Non-lnstitutional Category may be allocated to Bidders in the other sub-category of Non-lnstitutional Category in accordance with the SEBI ICDR Regulations, subject to valid Bids being received at or above the Issue Price. Further, not less than 35% of the Issue was available for allocation to Rlls (' Retail Category'), in accordance with the SEBI ICDR Regulations, subject to valid Bids being received from them at or above the Issue Price. All Bidders (except Anchor Investors) shall mandatorily participate in this Issue only through the Application Supported by Blocked Amount ('ASBA') process and shall provide details of their respective bank account (including UPI ID (defined hereinafter) in case of UPI Bidders (defined hereinafter) in which the Bid Amount will be blocked by the Self Certified Syndicate Banks | 'SCSBs") or the Sponsor Bank(s). as the case may be. Anchor Investors are not permitted to participate in the Anchor Investor Portion through the ASBAprocess. For details, see 'Issue Procedure' on page 400 of the Prospectus.

The bidding for Anchor Investor opened and closed on February 26.2024. The Company received 10 applications from lOAnchor Investors for 7,807.602 Equity Shares of which 7 such Anchor Investors through 7 Anchor Investor Application Forms were allocated 4.128,237 Equity Shares ata price of *171/- per Equity Share (including premium of Rs. 161/- per equity share) under the Anchor Investor Portion, aggregating to Rs. 705.928.527.00.

The Issue received 2.464,580 applications for 965.023,971 Equity Shares resulting in 70.12 times subscription as disclosed in the Prospectus. The detarts of the applications received in the Issue from Retail Individual Bidders. Non-Institutional Bidders and QIBs are as under (before technical rejections)

Final Demand

Asummary of the final demand as per NSE and BSE as on the Bid/ Issue Closing Date at different Bid Prices is as under:

The Basis of Allotment was finalized m consultation with the Designated Stock Exchange, being NSE on March 01.2024.

A. Allotment to Retail Individual Bidders (After Rejections) (including ASBA Applications)

The Basis of Allotment to the Retail Individual Bidders, who have bid at cut-off or at the Issue Price of * 171 per Equity, was finalized in consultation with NSE. This category has been subscribed to the extent of 50.1667 times. The total number of Equity Shares Allotted in Retail Individual Bidders category is 4.816.429 Equity Shares to 55.361 successful applicants The category-wise detarts of the Basis of Allotment are as under:

B. Allotment to Non-lnstitutional Bidders (more than 70.20 million and upto 71 million) (After Rejections) (including ASBA Applications)

The Basis of Allotment to the Non-lnstitutional Bidders (more than 7 0.20 million and upto 71 million), who have bed at the Issue Phoe of 7 171 per Equity Share or above, was finalized in consultation with NSE. This category has been subscribed to the extent of 148.8672 times. The total number of Equity Shares allotted in this category is 688.061 Equity Shares to 564 successful applicants. The category-wise details of the Basis of Allotment are as under: (Sample)

C. Allotment to Non-lnstitutional Bidders (more than million) (After Rejections) (including ASBA Applications)

The Basis of Allotment to the Non-lnstitutional Bidders (more than Rs.1 million), who have bid at the Issue Price of Rs.171 per Equity Share or above, was finalized in consultation with NSE. This category has been subsenbed to the extent of 138.0591 times. The total number of Equity Shares allotted in this category is 1,376,23 Equity Shares to 1,129 successful applicants. The category-wise details of the Basis of Allotment are as under: (Sample)

D. Allotment to QIBs (After Rejections)

Allotment to QIBs, who have bid at the Issue Price of Rs. 171 per Equity Share or above, has been done on a proportionate basis in consultation with NSE. This category has been subscribed to the extent of 150.1190 times of Net QIB portion. As per the SEBI Regulations. Mutual Funds were allotted 5% of the Equity Shares of Net QIB portion available i.e. 137.618 Equity Shares and other QIBs and unsatisfied demand of Mutual Funds were allotted the remaining available Equity Shares i.e. 2.614,757 Equity Shares on a proportionate basis. The total number of Equity Shares allotted in the QIB category is 2.752,375 Equity Shares, which were allotted to 84 successful Applicants.

E. Allotment to Anchor Investors (After Rejections)

The Company, in consultation with the BRIM, have allocated 4,128.237 Equity Shares to 7 Anchor Investors (through 10 Anchor Investor Application Forms) (including Nil domestic Mutual Funds through Nil schemes) at an Anchor Issue Price at Rs.171 per Equity Share in accordance with SEBIICDR Regulations. This represents 59.9981 % of the QIB portion.

The Board of Directors of our Company at its meeting held on March 01,2024 has taken on record the basis of allotment of Equity Shares approved by the Designated Stock Exchange, being NSE and has allotted the Equity Shares to various successful applicants. The Allotment Advice Cum Refund Intimation and/or notices have been dispatched to the address of the investors as registered with the depositories. Further, instructions to the SCSBs have been issued for unblocking of funds and transfer to the Public Issue Account on March 04.2024 and the payments to non-syndicate brokers have been issued on March 04.2024. In case the same is not received within ten days, investors may contact the Registrar to the Issue at the address given below. The Equity Shares allotted to the successful allottees have been uploaded on March 04.2024 for credit into the respective beneficiary accounts subject to validation of the account details with the depositories concerned. The Company has filed the Listing application with BSE and NSE on March 04,2024 The Company has received the listing and trading approval from BSE & NSE, and trading will commence on March 05,2024.

Note: All capitalized terms used and not defined herein shall have the respective meanings assigned to them in the Prospectus.

INVESTORS PLEASE NOTE

These details of the Allotment made was hosted on the website of Registrar to the Issue. BIGSHARE SERVICES PRIVATE LIMITED at www.bigshareonline.com.

All future correspondence in this regard may kindly be addressed to the Registrar to the Issue quoting full name of the First/ Sole applicant. Serial number of the Bid cum Application form number. Bidders DP ID. Client ID. PAN. date of submission of Bid cum Application Form, address of the Bidder, number of Equity Shares bid for. name of the Member of the Syndicate, place where the bid was submitted and payment details at the address given below:

THE LEVEL OF SUBSCRIPTION SHOULD NOT BE TAKEN TO BE INDICATIVE OF EITHER THE MARKET PRICE OF THE EQUITY SHARES ON LISTING OR THE BUSINESS PROSPECTS OF PLATINUM INDUSTRIES LIMITED.

PLATINUM INDUSTRIES LIMITED has filed the Prospectus dated March 01,2024 with Registrar of Companies, Maharashtra at Mumbai. The Prospectus shall be available on the website of the SEBI at www.sebi.gov.in. the website of the BRLM to the Issue at www.unistonecapital.com and websites of BSE and NSE i.e. www.bseindia.com and www.nseindta.com. respectively and the we&S'te of the Company at www.platinumindustnesltd.com. Investors should note that investment m equity shares involves a high degree of risk and for details relating to the same, see section titled "Risk Factors ' beginning on page 38 of the Prospectus. Potential investors should not rely on the DRHP for making any investment decision. Investors should instead rely on the information disclosed in the RHP.

The Equity Shares offered in the Issue have not been and will not be registered under the U S Secunties Act of 1933, as amended (the 'Securities Act') or any state securities laws in the United States, and unless so registered, may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and any applicable U.S. state securities laws. There will be no public offering in the United States and the securities being offered in this announcement are not being offered or sold in the United States.